Seòmar agus comataidhean

I refer the member to the answer to S6W-26400 on 19 April 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The final report from the NHS England-commissioned Independent Review of Gender Identity Services for Children and Young People (the ‘Cass Review’), chaired by Dr Hiliary Cass, was published on 10 April. The Cass Review did not review or consider clinical services as offered by Health Boards in Scotland.

However, both the Scottish Government and Scottish Health Boards had continued to proactively engage with the Cass Review as it progressed, to share information on improvement work in Scotland; shared learning; best practice; and to understand outputs of the review in England.

The Scottish Government welcomes the final report of the Cass Review, and we are now closely considering its findings at pace. Health Boards will also be considering the content of the report in the context of how this type of healthcare is delivered within Scotland.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

I refer the member to the answer to question S6W-26406 on 19 April 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The Sandyford Young People’s Gender Service, based in NHS Greater Glasgow and Clyde, is the only gender identity clinic in Scotland providing care to those aged under 17 years. This service offers a range of support to young people and their families and accepts referrals from across Scotland.

The information requested is not held centrally. This is a matter for NHS Greater Glasgow and Clyde as the responsible Health Board.

The Scottish Government has commissioned NHS National Services Scotland to work with a wide range of clinical and other stakeholders to consider how best to meet the needs of the population in terms of young people’s gender healthcare services for NHS Scotland. This work is ongoing, and aims to define the scope of a specialist service in Scotland.

The Scottish Government anticipates that an outline service specification based on this work will be presented to NHS Strategic Planning Board for Scotland for consideration later this year.

Scottish Government has confirmed funding for the Workforce Specialist Service (WSS) for 2024-25 and the current contract will be extended for a further 12 months. WSS provides confidential mental health assessment and treatment for regulated health, social care and social work professionals in Scotland.

The Digital Prescribing and Dispensing Pathways (DPDP) programme, is scheduled to replace the current paper prescription in Scotland with a digital approach by the end of this parliamentary term.

The business case which sets out the proposal for the next phase, and associated funding, for the programme are currently under consideration.

We do not know the numbers of children affected because the information has not been collected historically.

In response to the Independent Medicines and Medical Devices Safety Review (IMMDSR), the Scottish Government commissioned Public Health Scotland (PHS) to establish a medicines in pregnancy surveillance asset. This resource will support monitoring and reporting to progress improvements in the safe use of valproate and other teratogenic medicines in Scotland. Its first output is due to be published by PHS in April 2024 and will include prescribing data and trends for valproate and other anti-seizure medicines.

The Scottish Fire and Rescue Service (SFRS) naloxone programme was launched in February 2022, backed with investment of £89,000 from Scottish Government. The programme aims to establish a network of fire officers who will carry naloxone and be trained to administer it in the event of an emergency.

Since then, all SFRS staff have been invited to complete online training to learn more about drug deaths in Scotland and how naloxone can help someone in the event of an opioid overdose. To date, 3,379 out of all 7,619 staff have voluntarily completed the training.

There is additional training for Flexi Duty Officers (FDOs) who have volunteered to carry naloxone and there are now 31 trained FDO volunteers within SFRS who are able to do this. It is expected that over the next 6 weeks a further 130 FDO volunteers will be trained and equipped to carry and administer naloxone.

The carrying and administering Naloxone is considered by the Fire Brigades Union (FBU) to be a form of emergency medical response which currently sits out-with the role map of firefighters. SFRS has a desire to broaden the role of firefighters which would incorporate emergency medical response but this is dependent on reaching agreement with the FBU.

SFRS and Scottish Government are determined to fully implement this programme and will continue to work closely with all parties, including representative bodies, to overcome any barriers to its full implementation.

The Scottish Government will await the view and any decisions by the UK Government in relation to redress for anyone who was affected by exposure to valproate.

As set out in our letter to MSPs, this is because the recommendations on redress the UK Government is considering may involve a new agency and schemes that would be funded via a levy on manufacturers of medicines and medical devices and the Scottish Government has only limited powers under the devolution arrangements to impose levies.

We will of course update the Parliament about any important developments.